In a controversial move, President Donald Trump has signed an executive order directing the Justice Department to initiate lawsuits against states that do not provide religious and medical exemptions for school immunization requirements. The order introduces what it calls “Gold Standard Childhood Vaccine Recommendations,” trimming the list of diseases for mandatory vaccination from 18 to 11. The remaining vaccines would either target high-risk groups or be subject to “shared clinical decision-making” between parents and medical professionals.
This executive order has delineated several changes, including the recommendation to split the combined measles, mumps, and rubella vaccine into separate, single-disease shots and to administer vaccines in separate medical visits. Although these recommendations remain advisory, the order actively instructs the attorney general to contest state laws conflicting with parental rights, religious freedom, and disability accommodations as detailed here.
Under Section 3 of the order, the Department of Health and Human Services has been given a 90-day deadline to devise plans for single-antigen vaccines, modify timing and sequencing of doses, explore alternatives to aluminum adjuvants, and enhance safety monitoring. Meanwhile, ongoing litigation over alterations to the Advisory Committee on Immunization Practices has delayed previous initiatives. A notable lawsuit by the American Academy of Pediatrics led the District Court in Massachusetts to temporarily block changes to the immunization schedule, citing potential violations of the Administrative Procedure Act according to Reuters.
Complicating the scenario are rising voices of dissent. Senator Bill Cassidy, a physician, criticized the executive order for lacking grounding in scientific evidence and warned that fragmenting vaccine schedules could increase vaccination hesitancy and reduce safety. Furthermore, Dr. Jake Scott from Stanford Medical School pointed out the logistical challenges and potential decrease in completion rates for single-dose vaccines, which are no longer available since 2009.
The backdrop of these policy shifts is marked by a resurgence in vaccine-preventable diseases. Measles cases have already surpassed figures from previous years, and other diseases once considered under control are seeing a rise in incidence. A federal panel is soon to assess whether the U.S. retains its measles elimination status, a milestone it achieved in 2000 as reported by the New York Times.
As the nation grapples with these directives, the executive order’s impact on public health policies and legal disputes poses pressing questions about vaccine mandate governance, individual rights, and public well-being.